{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:01:14Z","timestamp":1784779274067,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Health Department of Hebei Province: Discussion on the Effect of Chloroquine Combined with Resveratrol on Oral Squamous Cell Carcinoma Cells","award":["20250447"],"award-info":[{"award-number":["20250447"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05367-w","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:51:34Z","timestamp":1777211494000},"page":"15335-15349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resveratrol synergizes with chloroquine to inhibit the malignant progression of oral squamous cell carcinoma by regulating KIF11"],"prefix":"10.1007","volume":"399","author":[{"given":"Jianfeng","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"2","key":"5367_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/ijms25020945","volume":"25","author":"NI Agalakova","year":"2024","unstructured":"Agalakova NI (2024) Chloroquine and chemotherapeutic compounds in experimental cancer treatment. Int J Mol Sci 25(2):945","journal-title":"Int J Mol Sci"},{"key":"5367_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104799","volume":"107","author":"A Almangush","year":"2020","unstructured":"Almangush A, M\u00e4kitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Su\u00e1rez C, Kowalski LP, Ferlito A et al (2020) Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol 107:104799","journal-title":"Oral Oncol"},{"issue":"1","key":"5367_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/pharmaceutics15010275","volume":"15","author":"G Angellotti","year":"2023","unstructured":"Angellotti G, Di Prima G, Belfiore E, Campisi G, De Caro V (2023) Chemopreventive and anticancer role of resveratrol against oral squamous cell carcinoma. Pharmaceutics 15(1):275","journal-title":"Pharmaceutics"},{"key":"5367_CR4","first-page":"1","volume":"17","author":"K Atoosa","year":"2024","unstructured":"Atoosa K, Vahide M, Niloufar M, Atefe R, Rohollah Mousavi D, Behrooz G, Mina A, Alireza M (2024) Regulating miRNAs expression by resveratrol: Novel insights based on molecular mechanism and strategies for cancer therapy. Curr Mol Pharmacol 17:1\u201321","journal-title":"Curr Mol Pharmacol"},{"key":"5367_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.freeradbiomed.2024.12.035","volume":"227","author":"M Benbelkacem","year":"2025","unstructured":"Benbelkacem M, Moulai N, Chader H, Ouahioune W, Bourouba M (2025) Dichloroacetate and chloroquine in combination with arsenite suppress ROS-induced oral squamous cell carcinoma (OSCC) development and improve BALB\/c mice survival. Free Radic Biol Med 227:593\u2013607","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"5367_CR6","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"5367_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.710304","volume":"12","author":"MH Ch\u00e1irez-Ram\u00edrez","year":"2021","unstructured":"Ch\u00e1irez-Ram\u00edrez MH, de la Cruz-L\u00f3pez KG, Garc\u00eda-Carranc\u00e1 A (2021) Polyphenols as antitumor agents targeting key players in cancer-driving signaling pathways. Front Pharmacol 12:710304","journal-title":"Front Pharmacol"},{"issue":"6","key":"5367_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13666","volume":"45","author":"WS Chang","year":"2021","unstructured":"Chang WS, Tsai CW, Yang JS, Hsu YM, Shih LC, Chiu HY, Bau DT, Tsai FJ (2021) Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK\/p-38 and suppression of MMP-2\/9. J Food Biochem 45(6):e13666","journal-title":"J Food Biochem"},{"issue":"5","key":"5367_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","volume":"16","author":"AD Colevas","year":"2018","unstructured":"Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ et al (2018) NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw 16(5):479\u2013490","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"5367_CR10","first-page":"155","volume":"52","author":"K Daigo","year":"2018","unstructured":"Daigo K, Takano A, Thang PM, Yoshitake Y, Shinohara M, Tohnai I, Murakami Y, Maegawa J, Daigo Y (2018) Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer. Int J Oncol 52(1):155\u2013165","journal-title":"Int J Oncol"},{"issue":"4","key":"5367_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/biom14040386","volume":"14","author":"W Gao","year":"2024","unstructured":"Gao W, Lu J, Yang Z, Li E, Cao Y, Xie L (2024) Mitotic functions and characters of KIF11 in cancers. Biomolecules 14(4):386","journal-title":"Biomolecules"},{"issue":"5","key":"5367_CR12","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.3892\/mmr.2017.7342","volume":"16","author":"L Jia","year":"2017","unstructured":"Jia L, Wang J, Wu T, Wu J, Ling J, Cheng B (2017) In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma. Mol Med Rep 16(5):5779\u20135786","journal-title":"Mol Med Rep"},{"issue":"1","key":"5367_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primers 6(1):92","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"5367_CR14","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1007\/s00210-024-03625-3","volume":"398","author":"CP Joshi","year":"2025","unstructured":"Joshi CP, Baldi A, Kumar N, Pradhan J (2025) Harnessing network pharmacology in drug discovery: an integrated approach. Naunyn Schmiedebergs Arch Pharmacol 398(5):4689\u20134703","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5367_CR15","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.2147\/IJN.S458910","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Meng Y, Zhang J, Gu L, Shen S, Zhu Y, Wang J (2024) Pharmacology progresses and applications of chloroquine in cancer therapy. Int J Nanomed 19:6777\u20136809","journal-title":"Int J Nanomed"},{"issue":"4","key":"5367_CR16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.7150\/ijbs.101921","volume":"21","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhu Y, Gu L, Li K, Ma A, Liu L, Meng Y, Zhang J, Shen S, Shi Q et al (2025) Chloroquine suppresses colorectal cancer progression via targeting CHKA and PFKM to inhibit the PI3K\/AKT pathway and the Warburg effect. Int J Biol Sci 21(4):1619\u20131631","journal-title":"Int J Biol Sci"},{"key":"5367_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2024.105897","volume":"160","author":"J Min","year":"2024","unstructured":"Min J, Mashimo C, Nambu T, Maruyama H, Takigawa H, Okinaga T (2024) Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum. Arch Oral Biol 160:105897","journal-title":"Arch Oral Biol"},{"issue":"3","key":"5367_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/0118744710335266250206060602","volume":"18","author":"M Mohammad","year":"2025","unstructured":"Mohammad M, Amir K, Faranak A, Elham A, Khodabakhsh R, Masoud N (2025) Mitigation of radiation-induced acute hematopoietic system and intestine injury by resveratrol-loaded polymeric nanoparticles after whole body irradiation in Mice. Curr Radiopharm 18(3):182\u2013200","journal-title":"Curr Radiopharm"},{"issue":"24","key":"5367_CR19","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.3390\/nu14245273","volume":"14","author":"M Nadile","year":"2022","unstructured":"Nadile M, Retsidou MI, Gioti K, Beloukas A, Tsiani E (2022) Resveratrol against cervical cancer: Evidence from in vitro and in vivo studies. Nutrients 14(24):5273","journal-title":"Nutrients"},{"issue":"1","key":"5367_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0115701646291510240212091951","volume":"21","author":"Z Nannan","year":"2024","unstructured":"Nannan Z, Junzhi L, Qiuping D, Chen L, Xinyu L, Peiyuan T, Zheng L (2024) Proteomic analysis of the molecular mechanisms of chlorpromazine inhibiting migration of oral squamous cell carcinoma. Curr Proteomics 21(1):2\u201313","journal-title":"Curr Proteomics"},{"issue":"3","key":"5367_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s10637-022-01238-2","volume":"40","author":"A Nicolai","year":"2022","unstructured":"Nicolai A, Taurone S, Carradori S, Artico M, Greco A, Costi R, Scarpa S (2022) The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells. Invest New Drugs 40(3):556\u2013564","journal-title":"Invest New Drugs"},{"issue":"4","key":"5367_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/omi.12412","volume":"38","author":"R Rahman","year":"2023","unstructured":"Rahman R, Shaikh MH, Gopinath D, Idris A, Johnson NW (2023) Human papillomavirus and Epstein-Barr virus co-infection in oral and oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis. Mol Oral Microbiol 38(4):259\u2013274","journal-title":"Mol Oral Microbiol"},{"key":"5367_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX, Liu C, Ma Z, Shanmugam MK, Ding L, Xiang X, Ho PC, Wang L, Ong PS et al (2021) Resveratrol for cancer therapy: Challenges and future perspectives. Cancer lett 515:63\u201372","journal-title":"Cancer lett"},{"issue":"2","key":"5367_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s11033-022-08072-y","volume":"50","author":"H Saini","year":"2023","unstructured":"Saini H, Choudhary M, Sharma H, Chowdhury S, Mukherjee S, Chowdhury R (2023) Chloroquine induces transitory attenuation of proliferation of human lung cancer cells through regulation of mutant P53 and YAP. Mol Biol Rep 50(2):1045\u20131058","journal-title":"Mol Biol Rep"},{"issue":"3","key":"5367_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00432-013-1575-1","volume":"140","author":"Z Shan","year":"2014","unstructured":"Shan Z, Yang G, Xiang W, Pei-jun W, Bin Z (2014) Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro. J Cancer Res Clin Oncol 140(3):371\u2013374","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"5367_CR26","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.3390\/nu16132141","volume":"16","author":"D Trautmann","year":"2024","unstructured":"Trautmann D, Suazo F, Torres K, Sim\u00f3n L (2024) Antitumor effects of resveratrol opposing mechanisms of helicobacter pylori in gastric cancer. Nutrients 16(13):2141","journal-title":"Nutrients"},{"issue":"1","key":"5367_CR27","doi-asserted-by":"publisher","first-page":"12179","DOI":"10.1038\/s41598-019-48717-w","volume":"9","author":"K Uzawa","year":"2019","unstructured":"Uzawa K, Amelio AL, Kasamatsu A, Saito T, Kita A, Fukamachi M, Sawai Y, Toeda Y, Eizuka K, Hayashi F et al (2019) Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma. Sci Rep 9(1):12179","journal-title":"Sci Rep"},{"issue":"29","key":"5367_CR28","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.2174\/1568026621666211105093658","volume":"21","author":"EK Vernousfaderani","year":"2021","unstructured":"Vernousfaderani EK, Akhtari N, Rezaei S, Rezaee Y, Shiranirad S, Mashhadi M, Hashemi A, Khankandi HP, Behzad S (2021) Resveratrol and colorectal cancer: a molecular approach to clinical researches. Curr Top Med Chem 21(29):2634\u20132646","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"5367_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1083\/jcb.201303163","volume":"202","author":"Y Wakana","year":"2013","unstructured":"Wakana Y, Villeneuve J, van Galen J, Cruz-Garcia D, Tagaya M, Malhotra V (2013) Kinesin-5\/Eg5 is important for transport of CARTS from the trans-Golgi network to the cell surface. J Cell Biol 202(2):241\u2013250","journal-title":"J Cell Biol"},{"issue":"13","key":"5367_CR30","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.2174\/1570180820666230719121428","volume":"21","author":"G Xin","year":"2024","unstructured":"Xin G, Xiao-Juan M, Bo H, Juan X, Jin-Song C (2024) Targets and mechanisms of resveratrol against endothelial-mesenchymal transition in atherosclerosis: a network pharmacology analysis combined with in vivo experiments. Lett Drug Des Discov 21(13):2760\u20132770","journal-title":"Lett Drug Des Discov"},{"issue":"1","key":"5367_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12672-025-02363-z","volume":"16","author":"R Zhang","year":"2025","unstructured":"Zhang R, Guo J, Lin Y (2025) Resveratrol inhibits the progression of oral squamouscell carcinoma through Norad\/Igf2bp2\/Pdk1 pathway and remodeling glucose metabolism reprogramming. Discov Oncol 16(1):603","journal-title":"Discov Oncol"},{"key":"5367_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, Liang Q (2023) Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Athnopharmacol 309:116306","journal-title":"J Athnopharmacol"},{"issue":"4","key":"5367_CR33","first-page":"1503","volume":"11","author":"ZH Zhou","year":"2021","unstructured":"Zhou ZH, Zhao TC, Liang SY, Zhang ZY, Zhu DW, Ju WT, Zhong LP (2021) A therapeutic approach with combination of interferon-gamma and autophagy inhibitor for oral squamous cell carcinoma. Am J Cancer Res 11(4):1503\u20131521","journal-title":"Am J Cancer Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05367-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:04:33Z","timestamp":1784775873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05367-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5367"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05367-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in strict accordance with the relevant regulations and requirements of the Declaration of Helsinki. Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of the Second Hospital of Hebei Medical University.The procedures performed on all animals complied with the standards formulated by the Experimental Animal Ethics Committee of the Second Hospital of Hebei Medical University and obtained the approval of the said committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}